Mov Disord Vol 31, Suppl 2 Archives - Page 41 of 207 - MDS Abstracts

2016 International Congress
A comparison study of health-related quality of life between female and male patients with Parkinson’s disease
B. Donmez Colakoglu, T. Kahraman, E. Goz, F. Soke, A. Genc, P. Keskinoglu (Izmir, Turkey)
Objective: To investigate the effect of gender difference on health-related quality of life in patients with Parkinson's disease (PD). Background: PD has a negative impact…
2016 International Congress
The social value of improvement in activities of daily living from levodopa-carbidopa intestinal gel use among the advanced Parkinson’s disease population
K. Sail, T. Shih, J. Sullivan, J. Yash, E. van Eijndhoven, C. Zadikoff, T. Marshall, D. Lakdawalla (Mettawa, IL, USA)
Objective: Quantify the value of improvement in functional status (FS) measured as activities of daily living (ADL) limitations, from levodopa-carbidopa intestinal gel (LCIG) use among…
2016 International Congress
Diagnostic sensitivity and remote monitoring of motor and non-motor dysfunction in Parkinson’s disease
K. Muhammed, S. Arora, M. Hu, M. Husain (Oxford, United Kingdom)
Objective: To determine if 24-hour tri-axial accelerometer and heart rate measurements can (1) discriminate Parkinson's disease (PD) from healthy controls and (2) monitor severity of…
2016 International Congress
mPower: A smartphone-based study of Parkinson’s disease provides personalized measures of disease impact
A.D. Trister, E.C. Neto, B.M. Bot, T. Perumal, A. Pratap, A. Klein, E.R. Dorsey, C.M. Tanner, S.H. Friend (Seattle, WA, USA)
Objective: mPower is a clinical observational study of Parkinson's disease (PD) conducted completely through an iPhone app focused on the ability of mobile devices and…
2016 International Congress
Ninjurin 1 gene D110a single nucleotide polymorphism as a genetic marker for nerve damage leprosy patients from South India
A. Sundaramoorthy, S. Keshavarao, A. Valsala Gopalakrishnan (Coimbatore, India)
Objective: Analyze the Ninjurin 1 gene single nucleotide polymorphisms in leprosy patients from south India, and the role of the gene in the nerve damage.…
2016 International Congress
Correlation among DNA methylation status and LINE-1 expression in rat brain
S. Mukherjee, K. Upadhyaya, D. Sharma (New Delhi, India)
Objective: Our objectives were to study the transcriptional expression of L1Rn elements in different brain regions and correlate with corresponding DNA methylation levels. Methods: Real…
2016 International Congress
Inflammatory profile discriminates clinical subtypes in LRRK2-associated PD
K. Brockmann, C. Schulte, N. Schneiderhan-Marra, A. Apel, C. Pont-Sunyer, D. Vilas, J. Ruiz-Martinez, M. Langkamp, J.C. Corvol, F. Cormier, T. Knorpp, T.O. Joos, A. Bernhard, T. Gasser, C. Marras, B. Schüle, J.O. Aasly, T. Foroud, J.F. Marti-Masso, A. Brice, E. Tolosa, D. Berg, W. Maetzler (Tübingen, Germany)
Objective: To evaluate whether inflammatory processes in PD patients with mutations in the LRRK2 gene (PD-LRRK2) are associated with modification of clinical features and disease…
2016 International Congress
Elevated SNCA expression in CD45+ peripheral blood cells in patients with dementia with Lewy bodies
N. Nikolaev, B. Lu.A., P.A. Andoskin, A. Emelyanov, A.E. Kopytova, K.A. Senkevich, I.V. Milyukhina, S.N. Pchelina (Saint-Petersburg, Russia)
Objective: To examine SNCA mRNA levels in CD45+ peripheral blood cells in patients with dementia with Lewy bodies (DLB), Parkinson's disease (PD) and individuals without…
2016 International Congress
Vitamin D receptor polymorphisms and Parkinson’s disease in a Korean population: Revisited
W. Jang, J.S. Kim (Gangneung, Korea)
Objective: We evaluated an association between PD and VDR polymorphisms including BsmI, FokI, ApaI, and TaqI and we also investigated the relationship between VDR polymorphisms…
2016 International Congress
SMPD1 mutations, acid-sphingomyelinase activity and α-synuclein accumulation in Parkinson’s disease
Z. Gan-Or, V. Mallett, O. Tavassoly, Y. Dauvilliers, C. Leblond, A. Ambalavanan, S. Laurent, S. Strong, D. Spiegelman, A. Dionne-Laporte, C. Liong, O. Levy, S. Fahn, C. Waters, P. Mazzoni, S. Kuo, W. Chung, B. Ford, K. Marder, U. Kang, P. Wolf, P. Oliva, X. Zhang, L. Clark, P. Dion, E. Fon, N. Dupre, G. Rouleau, R. Alcalay (Montreal, Canada)
Objective: To study the effects of SMPD1 (sphingomyelin phosphodiesterase-1 gene) variants and acid-sphingomyelinase (ASMase) activity on Parkinson's disease (PD), and the effect of SMPD1 knockdown…